Tag: Dialysis access
WAVE trial AVG cohort also benefits at six months with Wrapsody
Newly released six-month results from single-arm arteriovenous graft (AVG) cohort in the WAVE (Wrapsody arteriovenous access efficacy) trial showed target lesion and access circuit...
Vascular external support system use found to boost key functional outcomes...
Alik Farber, MD, professor of surgery and radiology at Boston University, is set to present the results of a multicenter U.S. study at the...
VasQ AVF creation device receives FDA clearance
Laminate Medical Technologies has announced their flagship device, the VasQ external vascular support, has been cleared by the Food and Drug Administration (FDA) for...
EndoAVF found usually less cost effective compared with sAVF
The Society for Clinical Vascular Surgery (SCVS) 50th Annual Symposium (25–29 March, Miami) hosted a series of abstract presentations. Among them was one by...
Amplifi vein dilation system continues to show promise following latest first-in-human...
An update from the first-in-human study assessing the Amplifi vein dilation system (Artio Medical) was delivered by Surendra Shenoy, MD, from Washington University School of...
MVSS 2022: Research on hemodialysis access surgery attracts inaugural Midwestern Vascular...
The authors behind a new study that found “significant differences” in hemodialysis vascular access outcomes after first-time arteriovenous (AV) fistula or graft creation “directly related” to...
Registry data highlight long-term trends in hemodialysis access profile of failed...
New findings, recently published in the Journal of Vascular Access (JVA), provide insight into the hemodialysis access profile of failed kidney transplant patients treated...
Houston, we have a dialysis access problem
The concept of dedicated vascular access centers fuels a turbocharged Texan tussle with Karl Illig, MD, of Flow Vascular Institute in Houston, taking on Eric...
Amplifi vein dilation system demonstrates ‘encouraging’ clinical results in hemodialysis access
Artio Medical announced that full results from its first-in-human clinical study of the Amplifi vein dilation system were presented at the 2021 VEITHSymposium (Nov....
IN.PACT AV DCB sustained ‘superior’ effectiveness in subgroups with high reintervention...
Several subgroups of patients treated with the IN.PACT AV drug-coated balloon (DCB) for arteriovenous fistulas (AVFs) demonstrated a “statistically significant” higher rate of target...
First-in-human study of Wrapsody endoprosthesis yields ‘very promising’ results
Merit Medical Systems has announced positive results from a prospective, observational, first-in-human study to evaluate the safety and effectiveness of Wrapsody—a self-expanding, cell-impermeable endoprosthesis...
CMS creates new billing code for central venous vascular access system
Bluegrass Vascular Technologies announced today that the Centers for Medicare & Medicaid Services (CMS) has finalized a new Healthcare Common Procedure Coding System (HCPCS)...
Enrollment starts in postmarket studies of WavelinQ endoAVF system
Enrollment has begun and the first patients have been treated in the postmarket surveillance study, CONNECT-AV, of the WavelinQ (BD) endovascular arteriovenous fistula (endoAVF)...
Wearable device for AV fistula remote monitoring shows promise—but faces commercial...
A new wearable device designed to remotely monitor arteriovenous (AV) fistulae function in dialysis access patients uncovered promising data, leading one set of researchers...
Physician assistant community launches ‘PA Case of the Month’
To help broaden its physician assistant (PA) members’ knowledge of vascular care and help them engage and interact with each other virtually, the Society...
New JVS associate editor for diversity traces footsteps of her mother
It took Journal of Vascular Surgery (JVS) associate editor Ulka Sachdev-Ost, MD, a while to realize just how much of an impact her mother’s...
Surfacer system IDE study results published
Bluegrass Vascular Technologies has announced the publication of the results of its prospective, multicenter SAVE-US (Surfacer system to facilitate access in venous occlusions—United States)...
CX 2020 LIVE: Vascular access session showcases new technologies, debate on...
The CX 2020 LIVE Vascular Access Consensus session sparked global interest, with chair Nick Inston (Birmingham, UK) and moderator Domenico Valenti (London, UK) taking questions...
Registry launches pair of studies on vascular complications related to COVID-19
The new Vascular Surgery COVID-19 Collaborative (VASCC) is ready to start collecting data on two projects.
The first study to emerge from the international registry,...
Dispatches from the vascular front: A view of COVID-19’s impact on...
Sharif Ellozy, MD, has had just about as near to a front row seat as it gets to the part of the United States...
National Kidney Foundation releases guideline for vascular access in dialysis patients
The American Journal of Kidney Diseases (AJKD) has published the National Kidney Foundation’s KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update, a completely revamped set...
Newly FDA-approved device for central venous occlusions hailed as exciting advance
HOUSTON—These are exciting times in the theater of dialysis access, expert in the field Eric Peden, MD, mused in the latter part of last...